Determinants of human immunodeficiency virus type 1 baseline susceptibility to the fusion inhibitors enfuvirtide and T-649 reside outside the peptide interaction site.

Source:http://linkedlifedata.com/resource/pubmed/id/15220433

Download in:

View as

General Info

PMID
15220433